<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v4.1.2 (http://www.squarespace.com/) on Fri, 09 May 2008 17:24:56 GMT--><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rss="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:cc="http://web.resource.org/cc/"><rss:channel rdf:about="http://themelanomablog.com/blogs/"><rss:title>The Melanoma Blog</rss:title><rss:link>http://themelanomablog.com/blogs/</rss:link><rss:description>First hand comments on surgical adjuvant treatment and therapy of metastatic treatment by Lynn Spitler, M.D., Director, Northern California Melanoma Center</rss:description><dc:language>en-US</dc:language><dc:date>2008-05-09T17:24:56Z</dc:date><admin:generatorAgent rdf:resource="http://www.squarespace.com/">Squarespace Site Server v4.1.2 (http://www.squarespace.com/)</admin:generatorAgent><rss:items><rdf:Seq><rdf:li rdf:resource="http://themelanomablog.com/blogs/2008/2/28/event-the-journey-through-cancer-the-seven-levels-of-healing.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2008/2/4/recall-of-gm-csf.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2008/1/30/clinical-trials-video.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/10/6/online-webcast.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/8/29/still-alive-by-hank-gardstein-md.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-long-term-adjuvant-pegylated-int.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-immunologic-effects-of-gm-csf.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting-summary.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting.html"/><rdf:li rdf:resource="http://themelanomablog.com/blogs/2007/5/27/asco-meeting.html"/></rdf:Seq></rss:items></rss:channel><rss:item rdf:about="http://themelanomablog.com/blogs/2008/2/28/event-the-journey-through-cancer-the-seven-levels-of-healing.html"><rss:title>Event: The Journey Through Cancer &amp; The Seven Levels of Healing</rss:title><rss:link>http://themelanomablog.com/blogs/2008/2/28/event-the-journey-through-cancer-the-seven-levels-of-healing.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2008-02-28T06:29:54Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2008/2/4/recall-of-gm-csf.html"><rss:title>Recall of GM-CSF</rss:title><rss:link>http://themelanomablog.com/blogs/2008/2/4/recall-of-gm-csf.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2008-02-04T16:28:58Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2008/1/30/clinical-trials-video.html"><rss:title>Clinical Trials Video</rss:title><rss:link>http://themelanomablog.com/blogs/2008/1/30/clinical-trials-video.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2008-01-30T01:50:01Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/10/6/online-webcast.html"><rss:title>ONLINE WEBCAST</rss:title><rss:link>http://themelanomablog.com/blogs/2007/10/6/online-webcast.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-10-06T23:15:23Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/8/29/still-alive-by-hank-gardstein-md.html"><rss:title>STILL ALIVE by HANK GARDSTEIN M.D.</rss:title><rss:link>http://themelanomablog.com/blogs/2007/8/29/still-alive-by-hank-gardstein-md.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-08-29T17:25:05Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-long-term-adjuvant-pegylated-int.html"><rss:title>2007 ASCO MEETING REPORT ON LONG-TERM ADJUVANT PEGYLATED INTERFERON-ALPHA2B</rss:title><rss:link>http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-long-term-adjuvant-pegylated-int.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-06-26T19:02:54Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-immunologic-effects-of-gm-csf.html"><rss:title>2007 ASCO MEETING - REPORT ON IMMUNOLOGIC EFFECTS OF GM-CSF</rss:title><rss:link>http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-immunologic-effects-of-gm-csf.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-06-26T18:32:43Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting-summary.html"><rss:title>2007 ASCO MEETING SUMMARY</rss:title><rss:link>http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting-summary.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-06-15T20:19:34Z</dc:date><dc:subject>Meetings</dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting.html"><rss:title>2007 ASCO MEETING</rss:title><rss:link>http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-06-15T20:19:32Z</dc:date><dc:subject></dc:subject></rss:item><rss:item rdf:about="http://themelanomablog.com/blogs/2007/5/27/asco-meeting.html"><rss:title>ASCO MEETING</rss:title><rss:link>http://themelanomablog.com/blogs/2007/5/27/asco-meeting.html</rss:link><dc:creator>Dr Lynn Spitler</dc:creator><dc:date>2007-05-27T15:53:28Z</dc:date><dc:subject></dc:subject></rss:item></rdf:RDF>